v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Stockholders' Deficit
ATS and SESB
Stockholders' Deficit
Global Impex LLC
Stockholders' Deficit
Amperics Holdings LLC
Stockholders' Deficit
Convertible debt
Stockholders' Deficit
Convertible promissory notes
Stockholders' Deficit
Common Stock
ATS and SESB
Common Stock
Global Impex LLC
Common Stock
Amperics Holdings LLC
Common Stock
Convertible debt
Common Stock
Convertible promissory notes
Common Stock
Additional Paid-In Capital
ATS and SESB
Additional Paid-In Capital
Global Impex LLC
Additional Paid-In Capital
Amperics Holdings LLC
Additional Paid-In Capital
Convertible debt
Additional Paid-In Capital
Convertible promissory notes
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling interest
CER
Noncontrolling interest
Global Impex LLC
Noncontrolling interest
ATS and SESB
CER
Global Impex LLC
Amperics Holdings LLC
Convertible debt
Convertible promissory notes
Total
Beginning balance (in shares) at Dec. 31, 2023                       416,826                                    
Beginning balance at Dec. 31, 2023           $ (9,456,219)           $ 42           $ 13,289,466 $ (22,860,351) $ 114,624     $ (26,345)             $ (9,482,564)
Increase (Decrease) in Stockholders' Equity                                                            
Other comprehensive income           51,383                           51,383                   51,383
Issuance of common stock in connection with the conversion of convertible debt and accrued interest 3a9 (in shares)                       33,362                                    
Issuance of common stock in connection with the conversion of convertible debt and accrued interest 3a9           3,779,223           $ 3           3,779,220                       $ 3,779,223
Issuance of common stock (in shares)                       519                                   249,039
Issuance of common stock           35,002           $ 0           35,002                       $ 35,002
Business combination with MCAC, net of transaction costs (in shares)                       209,419                                    
Business combination with MCAC, net of transaction costs           (6,672,972)           $ 21           (6,672,993)                       (6,672,972)
Acquisition of noncontrolling interest in connection with acquisition of a business                                             1,287,320             1,287,320
Issuance of common stock as consideration in acquisition of a business (in shares)                       5,000                                    
Issuance of common stock as consideration in acquisition of a business           161,440           $ 1           161,439                       161,440
Acquisition of additional noncontrolling shares           50,931                       50,931         (759)             50,172
Issuance of common stock to extinguish obligations to vendors and lenders under 3a10 plan (in shares)                       204,212                                    
Issuance of common stock to extinguish obligations to vendors and lenders under 3a10 plan           7,461,573           $ 20           7,461,553                       7,461,573
Issuance of common stock to vendors as consideration (in shares)                       27,656                                    
Issuance of common stock to vendors as consideration           1,729,350           $ 3           1,729,347                       1,729,350
Issuance of common stock to extinguish note payable, related party (in shares)                       3,906                                    
Issuance of common stock to extinguish note payable, related party           133,750                       133,750                       133,750
Issuance of common stock for Standby Equity Purchase Agreement (in shares)                       8,264                                    
Issuance of common stock for Standby Equity Purchase Agreement           187,500           $ 1           187,499                       187,500
Share based compensation expense           525                       525                       525
Net loss           (22,565,748)                         (22,565,748)       57,540             (22,508,208)
Ending balance (in shares) at Dec. 31, 2024                       909,165                                    
Ending balance at Dec. 31, 2024           (25,104,263)           $ 91           20,155,738 (45,426,099) 166,007     1,317,756             (23,786,507)
Increase (Decrease) in Stockholders' Equity                                                            
Other comprehensive income           10,781                           10,781                   10,781
Issuance of common stock to settle claim under Section 3(a)10 Settlement Agreement (see Note 12)           3,077,252                         0 0     0             3,077,252
Issuance of common stock to settle share reset derivative liabilities           1,712,005                                               1,712,005
Net loss           (7,018,410)                         (7,018,410)       41,071             (6,977,339)
Ending balance at Mar. 31, 2025           (27,322,635)                         (52,444,509) 176,788     1,358,827             (25,963,808)
Beginning balance (in shares) at Dec. 31, 2024                       909,165                                    
Beginning balance at Dec. 31, 2024           (25,104,263)           $ 91           20,155,738 (45,426,099) 166,007     1,317,756             (23,786,507)
Increase (Decrease) in Stockholders' Equity                                                            
Other comprehensive income           (186,340)                           (186,340)                   (186,340)
Issuance of common stock to settle claim under Section 3(a)10 Settlement Agreement ( see Note 9) (in shares)                       429,504                                    
Issuance of common stock to settle claim under Section 3(a)10 Settlement Agreement (see Note 12)           8,711,775           $ 43           8,711,732                       8,711,775
Issuance of common stock to settle share reset derivative liabilities (in shares)                       85,537                                    
Issuance of common stock to settle share reset derivative liabilities           1,712,005           $ 9           1,711,996                       1,712,005
Issuance of common stock to BOD and employees (in shares)                       86,197                                    
Issuance of common stock to BOD and employees           511,968           $ 9           511,959                       511,968
Issuance of common stock in connection with the conversion of convertible debt and accrued interest 3a9 (in shares)                   1,352,261 360,053                                      
Issuance of common stock in connection with the conversion of convertible debt and accrued interest 3a9       $ 6,553,602 $ 5,707,537         $ 135 $ 36         $ 6,553,467 $ 5,707,501                     $ 6,553,602 $ 5,707,537  
Acquisition of noncontrolling interest in connection with acquisition of a business                                         $ 613,286       $ 613,286          
Issuance of common stock as consideration in acquisition of a business (in shares)             153,125 1,040,625 84,375                                          
Issuance of common stock as consideration in acquisition of a business $ 3,199,480 $ 10,656,000 $ 864,000       $ 15 $ 104 $ 8       $ 3,199,463 $ 10,655,896 $ 863,992             $ 984,025   $ 3,199,480   $ 11,640,025 $ 864,000      
Issuance of common stock to vendors as consideration (in shares)                       19,313                                    
Issuance of common stock to vendors as consideration           175,776           $ 2           175,774                       175,776
Issuance of common stock for Standby Equity Purchase Agreement (in shares)                       119,307                                    
Issuance of common stock for Standby Equity Purchase Agreement           1,099,054           $ 12           1,099,042                       1,099,054
Issuance of common stock in connection with stock subscription (in shares)                       114,323                                    
Issuance of common stock in connection with stock subscription           805,000           $ 11           804,989                       805,000
Issuance of common stock in connection with share exchange agreement to settled accounts payable vendors (in shares)             35,445                                              
Issuance of common stock in connection with share exchange agreement to settled accounts payable vendors $ 12,474           $ 4           $ 12,472                     $ 12,474            
Net loss           (16,245,051)                         (16,245,050)       187,378             (16,057,673)
Ending balance (in shares) at Dec. 31, 2025                       4,789.23                                    
Ending balance at Dec. 31, 2025           (1,526,982)           $ 479           $ 60,164,021 (61,671,149) (20,333)     3,102,445             1,575,463
Increase (Decrease) in Stockholders' Equity                                                            
Other comprehensive income           (560,036)                           (560,036)                   (560,036)
Issuance of common stock to BOD and employees           220,757                                               220,757
Issuance of common stock for Standby Equity Purchase Agreement           93,199                                               93,199
Issuance of common stock in connection with share exchange agreement to settled accounts payable vendors           70,540                                               70,540
Net loss           (6,945,745)                         (6,945,745)       276,000             (6,669,745)
Ending balance at Mar. 31, 2026           $ (1,421,238)                         $ (68,616,894) $ (580,369)     $ 3,378,445             $ 1,957,207